Cyndea succesfully finished in July the first US Bioequivalence study for one of the products developed by its R&D department. This is a big milestone in the road of manufacturing for our US customers. Cyndea is nowadays developing up to 8 ANDAs. The Us market is a strategic territory where we at Cyndea want to […]
Dear customers, this note clarify we are not part of Gadea Pharmaceutical Group that was recently acquired by AMRI. It should be a minor mistake that some press media took wrong information based on the website of our old partner Gadea. The Gadea website has been updated removing any reference to Cyndea Pharma. Since September […]